Literature DB >> 28084340

Claudin-4 expression distinguishes SWI/SNF complex-deficient undifferentiated carcinomas from sarcomas.

Inga-Marie Schaefer1, Abbas Agaimy2, Christopher Dm Fletcher1, Jason L Hornick1.   

Abstract

Inactivation of SWI/SNF (switch/sucrose non-fermentable) chromatin remodeling complex subunits is a feature shared by select carcinomas and sarcomas with epithelioid morphology and variable keratin expression, making the distinction between carcinoma and sarcoma challenging in some cases. The tight junction-associated protein claudin-4 is a marker of epithelial differentiation that is expressed in nearly all carcinomas. Claudin-4 expression has been reported in the glandular component of biphasic synovial sarcoma but has not been systematically evaluated in other sarcoma types. In this study we assessed claudin-4 expression in SWI/SNF complex-deficient neoplasms showing loss of SMARCB1 (INI1), SMARCA4 (BRG1), or ARID1A and other sarcomas with epithelioid morphology. Immunohistochemistry for claudin-4 was performed on 130 neoplasms, including 90 soft tissue tumors with epithelioid morphology and/or SMARCB1 deficiency (20 epithelioid sarcomas (10 conventional, 10 proximal-type); 10 epithelioid angiosarcomas; 10 epithelioid hemangioendotheliomas; 15 epithelioid malignant peripheral nerve sheath tumors; 10 malignant rhabdoid tumors; 15 myoepithelial carcinomas; 10 biphasic synovial sarcomas), 10 ovarian clear cell carcinomas, 10 ovarian small cell carcinomas of hypercalcemic type, and 20 SWI/SNF complex-deficient undifferentiated carcinomas (14 SMARCB1 deficient and 6 SMARCA4 deficient, including rhabdoid carcinomas of various sites and sinonasal carcinomas). Membranous expression of claudin-4 (≥5% of cells) was observed in all biphasic synovial sarcomas (epithelial component only), all ovarian clear cell carcinomas, and 16 (80%) SWI/SNF complex-deficient undifferentiated carcinomas. All other soft tissue tumors were negative for claudin-4, with the exception of two myoepithelial carcinomas and one malignant rhabdoid tumor. Interestingly, none of the ovarian small cell carcinomas of hypercalcemic type expressed claudin-4. In summary, expression of claudin-4 is highly specific for true epithelial differentiation and may be useful to distinguish SWI/SNF complex-deficient undifferentiated carcinomas from sarcomas with epithelioid morphology. The lack of claudin-4 expression in ovarian small cell carcinomas of hypercalcemic type suggests that these tumors may be better regarded as sarcomas rather than carcinomas.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28084340     DOI: 10.1038/modpathol.2016.230

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  22 in total

Review 1.  Tight junction proteins.

Authors:  L González-Mariscal; A Betanzos; P Nava; B E Jaramillo
Journal:  Prog Biophys Mol Biol       Date:  2003-01       Impact factor: 3.667

2.  Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant.

Authors:  Johanna D Strehl; David L Wachter; Jutta Fiedler; Engelbert Heimerl; Matthias W Beckmann; Arndt Hartmann; Abbas Agaimy
Journal:  Ann Diagn Pathol       Date:  2015-04-07       Impact factor: 2.090

3.  Claudins in differential diagnosis between mesothelioma and metastatic adenocarcinoma of the pleura.

Authors:  Y Soini; V Kinnula; K Kahlos; P Pääkkö
Journal:  J Clin Pathol       Date:  2006-03       Impact factor: 3.411

4.  Five SWI/SNF gene products are components of a large multisubunit complex required for transcriptional enhancement.

Authors:  C L Peterson; A Dingwall; M P Scott
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

5.  Loss of expression of the SWI/SNF complex is a frequent event in undifferentiated/dedifferentiated urothelial carcinoma of the urinary tract.

Authors:  Abbas Agaimy; Simone Bertz; Liang Cheng; Ondrej Hes; Kerstin Junker; Bastian Keck; Antonio Lopez-Beltran; Michael Stöckle; Bernd Wullich; Arndt Hartmann
Journal:  Virchows Arch       Date:  2016-06-23       Impact factor: 4.064

6.  Epigenetic regulation of SMARCB1 By miR-206, -381 and -671-5p is evident in a variety of SMARCB1 immunonegative soft tissue sarcomas, while miR-765 appears specific for epithelioid sarcoma. A miRNA study of 223 soft tissue sarcomas.

Authors:  Zoltán Sápi; Gergő Papp; Miklós Szendrői; Zsuzsanna Pápai; Vanda Plótár; Thomas Krausz; Christopher D M Fletcher
Journal:  Genes Chromosomes Cancer       Date:  2016-06-24       Impact factor: 5.006

7.  Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy.

Authors:  Cigall Kadoch; Diana C Hargreaves; Courtney Hodges; Laura Elias; Lena Ho; Jeff Ranish; Gerald R Crabtree
Journal:  Nat Genet       Date:  2013-05-05       Impact factor: 38.330

8.  Claudin 4 identifies a wide spectrum of epithelial neoplasms and represents a very useful marker for carcinoma versus mesothelioma diagnosis in pleural and peritoneal biopsies and effusions.

Authors:  Fabio Facchetti; Silvia Lonardi; Francesca Gentili; Luisa Bercich; Marcella Falchetti; Regina Tardanico; Carla Baronchelli; Laura Lucini; Alessandro Santin; Bruno Murer
Journal:  Virchows Arch       Date:  2007-07-03       Impact factor: 4.064

9.  SMARCB1(INI1)-deficient sinonasal basaloid carcinoma: a novel member of the expanding family of SMARCB1-deficient neoplasms.

Authors:  Abbas Agaimy; Michael Koch; Michael Lell; Sabine Semrau; Wojciech Dudek; David L Wachter; Antje Knöll; Heinrich Iro; Florian Haller; Arndt Hartmann
Journal:  Am J Surg Pathol       Date:  2014-09       Impact factor: 6.394

Review 10.  Mammalian SWI/SNF chromatin remodeling complexes and cancer: Mechanistic insights gained from human genomics.

Authors:  Cigall Kadoch; Gerald R Crabtree
Journal:  Sci Adv       Date:  2015-06-12       Impact factor: 14.136

View more
  18 in total

1.  SWI/SNF complex-deficient soft tissue neoplasms: An update.

Authors:  Inga-Marie Schaefer; Jason L Hornick
Journal:  Semin Diagn Pathol       Date:  2020-06-05       Impact factor: 3.464

Review 2.  What is new in epithelioid soft tissue tumors?

Authors:  Abbas Agaimy
Journal:  Virchows Arch       Date:  2019-11-04       Impact factor: 4.064

3.  NUTM1 Gene Fusions Characterize a Subset of Undifferentiated Soft Tissue and Visceral Tumors.

Authors:  Brendan C Dickson; Yun-Shao Sung; Marc K Rosenblum; Victor E Reuter; Mohammed Harb; Jay S Wunder; David Swanson; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2018-05       Impact factor: 6.394

4.  Clinicopathological and molecular characterization of SMARCA4-deficient thoracic sarcomas with comparison to potentially related entities.

Authors:  Akihiko Yoshida; Eisuke Kobayashi; Takashi Kubo; Makoto Kodaira; Toru Motoi; Noriko Motoi; Kan Yonemori; Yuichiro Ohe; Shun-Ichi Watanabe; Akira Kawai; Takashi Kohno; Hiroshi Kishimoto; Hitoshi Ichikawa; Nobuyoshi Hiraoka
Journal:  Mod Pathol       Date:  2017-03-03       Impact factor: 7.842

5.  SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior.

Authors:  Jennifer L Sauter; Rondell P Graham; Brandon T Larsen; Sarah M Jenkins; Anja C Roden; Jennifer M Boland
Journal:  Mod Pathol       Date:  2017-06-23       Impact factor: 7.842

Review 6.  Epigenetic Alterations in Bone and Soft Tissue Tumors.

Authors:  John Wojcik; Kumarasen Cooper
Journal:  Adv Anat Pathol       Date:  2017-11       Impact factor: 3.875

Review 7.  SWI/SNF Complex Mutations in Gynecologic Cancers: Molecular Mechanisms and Models.

Authors:  Yemin Wang; Lien Hoang; Jennifer X Ji; David G Huntsman
Journal:  Annu Rev Pathol       Date:  2020-01-24       Impact factor: 23.472

8.  Cytomorphologic Spectrum of SMARCB1-Deficient Soft Tissue Neoplasms.

Authors:  Inga-Marie Schaefer; Alyaa Al-Ibraheemi; Xiaohua Qian
Journal:  Am J Clin Pathol       Date:  2021-07-06       Impact factor: 2.493

9.  Round Cell Sarcoma with EWSR1-PATZ1 Fusion in the Face of a Five-Year-Old Boy: Report of a Case with Unusual Histologic Features.

Authors:  Derek Tsz Wai Yau; Shun Wong; Chit Chow; Ka Fai To
Journal:  Head Neck Pathol       Date:  2021-01-18

10.  Cytologic features of undifferentiated and dedifferentiated carcinomas of the endometrium.

Authors:  Amir-Hossein Akbari; Lu Wang; Robert A Soslow; Rajmohan Murali
Journal:  Cancer Cytopathol       Date:  2020-09-16       Impact factor: 5.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.